These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
517 related articles for article (PubMed ID: 27326985)
1. Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal. Sánchez J; Zakzuk J; Cardona R J Investig Allergol Clin Immunol; 2016; 26(3):177-84. PubMed ID: 27326985 [TBL] [Abstract][Full Text] [Related]
2. Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours. Purohit A; Melac M; Pauli G; Frossard N Ann Allergy Asthma Immunol; 2004 Jun; 92(6):635-40. PubMed ID: 15237765 [TBL] [Abstract][Full Text] [Related]
3. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial]. Kłos K; Kruszewski J; Kruszewski R; Sułek K Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838 [TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Grant JA; Riethuisen JM; Moulaert B; DeVos C Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924 [TBL] [Abstract][Full Text] [Related]
5. Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction. Purohit A; N'Gom AS; Deslandes B; Pauli G; Frossard N Ann Allergy Asthma Immunol; 2004 Dec; 93(6):562-7. PubMed ID: 15609766 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. Wan KS J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267 [TBL] [Abstract][Full Text] [Related]
7. Comparative Efficacy of Fexofenadine Versus Levocetrizine Versus Desloratadine via 1% Histamine Wheal Suppression Test. Kc S; Aryal A; Adhikary M; Karn D Kathmandu Univ Med J (KUMJ); 2020 Jan.-Mar; 18(69):19-22. PubMed ID: 33582682 [TBL] [Abstract][Full Text] [Related]
8. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers. Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial]. Kruszewski J; Kłos K; Sułek K Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837 [TBL] [Abstract][Full Text] [Related]
10. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes. Grob JJ; Lachapelle JM Curr Med Res Opin; 2008 Aug; 24(8):2423-8. PubMed ID: 18651988 [TBL] [Abstract][Full Text] [Related]
11. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers. Frossard N; Benabdesselam O; Purohit A; Mounedji N; Pauli G Fundam Clin Pharmacol; 2000; 14(4):409-13. PubMed ID: 11030449 [TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of 5 and 10 mg oral desloratadine and levocetirizine on histamine-induced wheal and flare response in healthy volunteers. Bulca S; Bayramgürler D; Odyakmaz Demirsoy E; Yavuz M; Sikar Aktürk A; Bilen N; Kıran R J Dermatolog Treat; 2013 Dec; 24(6):473-6. PubMed ID: 23441762 [TBL] [Abstract][Full Text] [Related]
13. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses. Bayramgürler D; Bilen N; Apaydýn R; Altintaş L; Sal G; Dökmeci S; Utkan T Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333 [TBL] [Abstract][Full Text] [Related]
14. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy. Roongapinun S; Wajajamreon S; Fooanant S J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528 [TBL] [Abstract][Full Text] [Related]
16. Antihistamines do not inhibit the flare induced by the intradermal injection of autologous plasma in chronic urticaria patients. Asero R; Tedeschi A; Lorini M; Cugno M Eur Ann Allergy Clin Immunol; 2009 Dec; 41(6):181-6. PubMed ID: 20128232 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers. Antonijoan R; Coimbra J; García-Gea C; Puntes M; Gich I; Campo C; Valiente R; Labeaga L Curr Med Res Opin; 2017 Jan; 33(1):129-136. PubMed ID: 27659218 [TBL] [Abstract][Full Text] [Related]
18. Antihistamines do not inhibit the wheal induced by the intradermal injection of autologous serum in resistant chronic idiopathic urticaria. Magen E; Mishal J; Zeldin Y; Schlesinger M Allergy Asthma Proc; 2012; 33(6):531-7. PubMed ID: 23394513 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges. Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645 [TBL] [Abstract][Full Text] [Related]
20. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil. Maciel-Guerra H; Penha MÁ; Jorge MFS; Libório RDS; Carrijo ACNDA; Parise-Fortes MR; Miot HA An Bras Dermatol; 2018 Mar; 93(2):233-237. PubMed ID: 29723372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]